EP4496554A1 - Cosmetic emulsion with reduced white foaming - Google Patents

Cosmetic emulsion with reduced white foaming

Info

Publication number
EP4496554A1
EP4496554A1 EP22942056.7A EP22942056A EP4496554A1 EP 4496554 A1 EP4496554 A1 EP 4496554A1 EP 22942056 A EP22942056 A EP 22942056A EP 4496554 A1 EP4496554 A1 EP 4496554A1
Authority
EP
European Patent Office
Prior art keywords
weight
emulsion
stearate
palmitate
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22942056.7A
Other languages
German (de)
French (fr)
Other versions
EP4496554A4 (en
Inventor
Julia Eckert
Claudia Mueller
Fasong LI
Yan Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nivea Shanghai Co Ltd
Beiersdorf AG
Original Assignee
Niva Shanghai Co Ltd
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niva Shanghai Co Ltd, Beiersdorf AG filed Critical Niva Shanghai Co Ltd
Publication of EP4496554A1 publication Critical patent/EP4496554A1/en
Publication of EP4496554A4 publication Critical patent/EP4496554A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group

Definitions

  • the present invention belongs to the cosmetic field and relates to a cosmetic emulsion which shows reduced levels of white appearance after application.
  • Cosmetic products generally not only serve to look beautiful and attractive, but their effects make a decisive contribution to increased self-esteem and people's wellbeing. Accordingly, a wide variety of cosmetic products are used for the daily cleaning and care of human skin.
  • anti-foaming agents are included in body lotions and creams which reduce the time until the air bubbles and with it the white foam disappears. If no anti-foaming agents are used, the white foam will need longer time to disappear, and the spreading/massage upon application to the skin will increase the foaming. Thus, for consumers, the skin care product will become whiter and whiter during applying, although finally it will disappear. As a result, the consumer will have the impression that the product is difficult to spread and absorb.
  • the anti-foaming agents can help the air bubbles break and disappear faster, so the product seems to be easier spread and faster absorbed on skin.
  • silicone oils are used as anti-foaming agent.
  • E. g. dimethicone has low surface tension and is not easy to dissolve into water or other oil ingredients. As result it can easily move to the surface of the air bubbles and spread on the bubble surface. This process renders the surface of the bubble to become uneven so that the bubbles start to combine and break faster.
  • Typical silicone oil based anti-foaming compositions are described in US5531929 A.
  • EP 0339958 A3 describes encapsulated silicone anti-foaming compositions.
  • Lexgard MG Natural MB is known under the INCI designation methylhepylglycerin. Datasheets suggest that it can be used as anti-foaming agent. However, the anti-foaming capabilities of this material are still limited.
  • a first object of the present invention is a cosmetic emulsion comprising based on the total weight of the composition
  • the emulsions according to the invention allow the appearance of foaming after application to be reduced. It was surprising that a synergism was observed between the compounds.
  • normal conditions refers to 20°C, 1013 hPa and a relative humidity of 50%.
  • the term “free from” means that the proportion of the respective substance is less than 0.05%by weight. This ensures that entrainments or impurities with these substances are not included as “free from” according to the invention.
  • skin refers solely to the human skin.
  • Fatty alcohols are understood as primary alcohols having 6 to 22 carbon atoms.
  • Silicone compounds are understood as substances comprising a dimethylsiloxane subunit (SiO (CH 3 ) 2 ) in its chemical structure.
  • Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name “emulsifying agent” .
  • Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name “surfactant” .
  • the emulsion according to the invention comprises from 0.05 to 5%by weight of methylheptylglycerin. It is preferred if the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, more preferably from 0.2 to 1.5%by weight and most preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
  • the emulsion comprises at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated
  • the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • Preferred esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl
  • isopropyl myristate and/or isopropyl palmitate are particular preferred.
  • esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms which may be hydroxylated, selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isonononon
  • the total quantity of isopropyl myristate and/or isopropyl palmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • At least one fatty acid triglyceride is contained in the emulsion.
  • the total quantity of the fatty acid triglycerides is preferably in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  • the fatty acid triglyceride is selected from Cocos Nucifera Oil (Triglyceride (Fractionated Coconut Oil) ) , Astrocaryum Murumuru Seed Butter (Astrocaryum sp Triglycerides) , C10-18 Triglycerides, C10-40 Isoalkyl Acid Triglyceride, C12-18 Acid Triglyceride, C18-36 Acid Triglyceride, C8-12 Acid Triglyceride, Caprylic/capric/myristic/stearic Triglyceride, Caprylic/Capric Triglyceride, Capric/Lauric/Myristic/Oleic Triglyceride, Caprylic/Capric/Linoleic Triglyceride, Caprylic/Capric/Stearic Triglyceride, Castoryl Maleate (Ceraphyl RMT (Ricinoleyl Monomaleate Triglyceride) ) , Hydrogenated C12-18 Triglycerides,
  • Caprylic/Capric Triglyceride In particular preferred is Caprylic/Capric Triglyceride.
  • the total quantity of the Caprylic/Capric Triglyceride is in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  • the fatty acid triglyceride can also be part of natural oils.
  • Preferred natural oils which can be contained are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, avocado oil, tea tree oil, soybean oil, glycine soja oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango kernel oil, cuckoo flower oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter, and shea butter.
  • the emulsion comprises least one fatty alcohol ether. It is preferred if the emulsion comprises distearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether as fatty alcohol ether. Further it is preferred if total quantity of fatty alcohol ether is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • total quantity of distearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5 %by weight, calculated to the total weight of the emulsion. Most preferred is dicaprylyl ether.
  • the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with acrylic acid and/or methacrylic.
  • the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with 2-acrylamido-2-methylpropanesulfonic acid.
  • the oil phase of the emulsion sums up to a total quantity in the range from 3.0 to 20.0%by weight, more preferably from 5.0 to 15%by weight and most preferably from 6.0 to 12.0%by weight, calculated to the total weight of the emulsion.
  • emulsifier and surfactants are not part of the oil phase. Nevertheless, fatty alcohols count as part of the oil phase.
  • Further compounds which can be contained in the oil phase are for example chosen from further branched saturated or unsaturated fatty alcohols having 6-30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols since they are obtainable according to the Guerbet reaction.
  • Preferred alcohol oils are hexyldecanol ( G 16, T 16) , octyldodecanol ( G, 20) and 2-ethylhexyl alcohol.
  • oils preferred according to the invention are chosen from the addition products of from 1 to 5 propylene oxide units onto mono-or polyhydric C8-22-alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether ( APM) .
  • mono-or polyhydric C8-22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether ( APM) .
  • oils which can be contained in the emulsion according to the invention are chosen from the addition products of at least 6 ethylene oxide and/or propylene oxide units onto mono-or polyhydric C3-22-alkanols, such as butanol, butanediol, myristyl alcohol and stearyl alcohol, e.g., PPG-14 butyl ether (Ucon AP) , PPG-9 butyl ether ( B25) , PPG-10 butanediol ( 57) and PPG-15 stearyl ether ( E) .
  • PPG-14 butyl ether Ucon AP
  • PPG-9 butyl ether B25
  • PPG-10 butanediol 57
  • PPG-15 stearyl ether E
  • Further oils are preferbly chosen from the C8-C22-fatty alcohol esters of monobasic or polybasic C2-C7-hydroxycarboxylic acids, in particular, the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • esters based on linear C14/15-alkanols, e.g., C12-C15-alkyl lactate, and on C12/13-alkanols branched in the 2 position are available under the trade name from Nordmann, Rassmann GmbH &Co., Hamburg, in particular the commercial products ESI, EMI and ETI.
  • oils which can preferably be used are chosen from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, e.g., glycerol carbonate, dicaprylyl carbonate ( CC) or the esters of DE 197 56 454 A1.
  • the emulsion comprises at least one fatty alcohol comprising 12 to 22 carbon atoms.
  • fatty alcohols cetyl alcohol, stearyl alcohol and the corresponding mixture cetearyl alcohol are most preferred.
  • the total quantity of those fatty alcohols is in the range from 0.5 to 8.0%by weight, more preferably 1.5 to 6.0%by weight and most preferably 2.5 to 5.0 %by weight, calculated to the total weight of the emulsion.
  • the emulsion comprises 0.05 to 1%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition. Those gums allow to build up a hydrogel structure in the formulation.
  • At least xanthan gum is contained. Further it is particular preferred if at least gellan gum is contained. Further it is particular preferred if at least sclerotium gum is contained. Further it is particular preferred if at least dehydroxanthan gum is contained.
  • the emulsion comprises 0.1 to 0.8%by weight, more preferably 0.12 to 0.5%by weight and most preferably 0.15 to 0.3%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition.
  • xanthan gum Most preferred is the combination of xanthan gum and gellan gum.
  • the emulsion according to the invention comprises further short chain polyols comprising 2 to 8 carbon atoms.
  • those preferred polyols are contained in quantities ranging from 0.5 to 10%by weight, more preferably 1 to 9%by weight and most preferably from 1.5 to 8%by weight, calculated to the total weight of the composition.
  • the emulsion comprises phenoxyethanol and/or ethylhexylglycerin.
  • phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 2.0%by weight, preferably from 0.6 to 1.4%by weight, calculated to the total weight of the emulsion.
  • ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 1.2%by weight, calculated to the total weight of the emulsion.
  • nonionic emulsifier is contained.
  • nonionic emulsifiers are selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil.
  • glyceryl stearate and/or glyceryl stearate SE are particularly preferred.
  • the total quantity of the nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
  • nonionic emulsifier selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil
  • the total quantity of those nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
  • At least one anionic emulsifier is contained, which is advantageously selected from the group of anionic emulsifiers having a hlb value ranging from 8 to 18, in particular from 10 to 15.
  • Preferred anionic emulsifiers are selected from glyceryl stearate citrate, sodium cetearyl sulfate and glyceryl citrate.
  • the total quantity of anionic emulsifier is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
  • the total quantity of glyceryl stearate citrate, sodium cetearyl sulfate and/or glyceryl citrate is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
  • active ingredients are contained. These are advantageously selected from the group containing sodium hyaluronate, 1-methylhydantoin-2-imide, creatine, folic acid, panthenol, pantolactone, vitamin C, magnolia, calcium pantothenate and sodium ascorbyl phosphate.
  • the active ingredients mentioned in the group are advantageously used in total proportions of up to 2%by weight, preferably less than 1%by weight, based on the total weight of the composition.
  • the emulsion is an oil in water emulsion.
  • water is contained in the emulsion in a total quantity ranging from 75.0%by weight to 95.0%by weight, calculated to the total weight of the emulsion.
  • Figure 1 shows a picture of Example 1
  • Figure 2 shows a picture of Example 2
  • Figure 3 shows a picture of Example 3.
  • Figure 4 shows a picture of Example 4.
  • Ex. 2 is according to the invention.
  • Ex. 1, Ex. 3 and Ex. 4 are reference examples.
  • test sample test sample
  • Pipette which can measure 200 ⁇ L sample
  • artificial skin black PU artificial leather
  • metronome stopwatch
  • camera photograph light box
  • camera fixing system
  • imageJ image analyze software
  • Example 1 in the table above is a reference example containing methylheptylglycerin.
  • Example 2 is an example according to the invention containing methylheptylglycerin and isopropylpalmitate. If another oil, e.g., octyldodecanol is added an increase in white foam is observed (Ex. 4) . This applies also, if only the ester is used in absence of methylheptylglycerin (Ex. 3) . Thus, only by applying isopropyl palmitate in combination with methylheptylglycerin allows a synergistic reduction of white foam (Figure 2) .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

A cosmetic emulsion which shows reduced levels of white appearance after application. Specifically, the cosmetic emulsion comprises methylheptylglycerin and at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, preferably isopropyl myristate and/or isopropyl palmitate.

Description

    Cosmetic emulsion with reduced white foaming Technical field
  • The present invention belongs to the cosmetic field and relates to a cosmetic emulsion which shows reduced levels of white appearance after application.
  • Background art
  • Cosmetic products generally not only serve to look beautiful and attractive, but their effects make a decisive contribution to increased self-esteem and people's wellbeing. Accordingly, a wide variety of cosmetic products are used for the daily cleaning and care of human skin.
  • When applying cosmetic products such as body lotions and creams which contain an oil and an aqueous phase it is often observed that small air bubbles of the composition are formed on the skin. These air bubbles can be described as foam which has a white appearance. Typically, this foam disappears in a couple of minutes after application to the skin.
  • In most cases anti-foaming agents are included in body lotions and creams which reduce the time until the air bubbles and with it the white foam disappears. If no anti-foaming agents are used, the white foam will need longer time to disappear, and the spreading/massage upon application to the skin will increase the foaming. Thus, for consumers, the skin care product will become whiter and whiter during applying, although finally it will disappear. As a result, the consumer will have the impression that the product is difficult to spread and absorb. The anti-foaming agents can help the air bubbles break and disappear faster, so the product seems to be easier spread and faster absorbed on skin.
  • Most often silicone oils are used as anti-foaming agent. E. g. dimethicone has low surface tension and is not easy to dissolve into water or other oil ingredients. As result it can easily move to the surface of the air bubbles and spread on the bubble surface. This process renders the surface of the bubble to become uneven so that the bubbles start to combine and break faster.
  • Typical silicone oil based anti-foaming compositions are described in US5531929 A. EP 0339958 A3 describes encapsulated silicone anti-foaming compositions.
  • However, the use of silicone oils has been controversially discussed for various reasons in recent years. Thus, consumers generally prefer products which do not require the presence of silicone oils. Nevertheless, the appearance of foam upon applications shall remain at a  limited level. That means the amount of foam and the time upon disappearance of the white foam shall be reduced.
  • Lexgard MG Natural MB is known under the INCI designation methylhepylglycerin. Datasheets suggest that it can be used as anti-foaming agent. However, the anti-foaming capabilities of this material are still limited.
  • Summary of the invention
  • It was surprisingly found by the application that the objectives can be met by the present invention.
  • A first object of the present invention is a cosmetic emulsion comprising based on the total weight of the composition
  • a. 0.05 to 5.0%by weight of methylheptylglycerin,
  • b. At least one oil chosen from ethers of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated,
  • c. less than 0.1%or 0%by weight of a silicone oil and/or a silicone compound.
  • It was surprisingly noticed that the emulsions according to the invention allow the appearance of foaming after application to be reduced. It was surprising that a synergism was observed between the compounds.
  • All the weight percentages (%by weight) given below relate, unless otherwise stated, to the total weight of the cosmetic emulsion. If ratios of certain components are disclosed in the following description, these ratios refer, unless otherwise stated, to weight ratios of the components.
  • Unless otherwise stated, all tests and measurements were performed under “normal conditions” . The term "normal conditions" refers to 20℃, 1013 hPa and a relative humidity of 50%.
  • In the following description the terms ” according to the invention” , “preferred according to the invention” and so on are always directed to the use according to the invention, to the composition and to the method according to the invention.
  • For the purposes of the present disclosure, the term "free from" means that the proportion of the respective substance is less than 0.05%by weight. This ensures that entrainments or impurities with these substances are not included as "free from" according to the invention.
  • The term “skin” refers solely to the human skin.
  • Fatty alcohols are understood as primary alcohols having 6 to 22 carbon atoms.
  • Silicone compounds are understood as substances comprising a dimethylsiloxane subunit (SiO (CH 32) in its chemical structure.
  • Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emulsifying agent" . Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "surfactant" .
  • The emulsion according to the invention comprises from 0.05 to 5%by weight of methylheptylglycerin. It is preferred if the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, more preferably from 0.2 to 1.5%by weight and most preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
  • According to the invention the emulsion comprises at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated
  • According to the invention, it is preferred if the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • Preferred esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2-butyl octanoate, diisotridecyl acetate, ethyl stearate, methyl stearate, , propyl stearate, butyl stearate, ethyl myristate, ethyl palmitate, butyl palmitate, propyl stearate, propyl palmitate, stearyl benzoate, benzyl palmitate, benzyl stearate, palmityl benzoate, C12-15 alkyl benzoate, palmityl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and ethylene glycol dipalmitate.
  • Among those isopropyl myristate and/or isopropyl palmitate are particular preferred.
  • Accordingly it is preferred if the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2-butyl octanoate, diisotridecyl acetate, ethyl stearate, methyl stearate, , propyl stearate, butyl stearate, ethyl myristate, ethyl palmitate, butyl palmitate, propyl stearate, propyl palmitate, stearyl benzoate, benzyl palmitate, benzyl stearate, palmityl benzoate, C12-15 alkyl benzoate, palmityl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and ethylene glycol dipalmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • Further it is preferred if the total quantity of isopropyl myristate and/or isopropyl palmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more  preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  • Further it is preferred if at least one fatty acid triglyceride is contained in the emulsion. The total quantity of the fatty acid triglycerides is preferably in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  • It is preferred if the fatty acid triglyceride is selected from Cocos Nucifera Oil (Triglyceride (Fractionated Coconut Oil) ) , Astrocaryum Murumuru Seed Butter (Astrocaryum sp Triglycerides) , C10-18 Triglycerides, C10-40 Isoalkyl Acid Triglyceride, C12-18 Acid Triglyceride, C18-36 Acid Triglyceride, C8-12 Acid Triglyceride, Caprylic/capric/myristic/stearic Triglyceride, Caprylic/Capric Triglyceride, Capric/Lauric/Myristic/Oleic Triglyceride, Caprylic/Capric/Linoleic Triglyceride, Caprylic/Capric/Stearic Triglyceride, Castoryl Maleate (Ceraphyl RMT (Ricinoleyl Monomaleate Triglyceride) ) , Hydrogenated C12-18 Triglycerides, Lauric/palmitic/oleic Triglyceride, Mustelic/palmitic Triglyceride, Oleic/linoleic Triglyceride, Oleic/Palmitic/Lauric/Myristic/Linoleic Triglyceride, Ricinoleic/caproic/caprylic/capric Triglyceride, Caprylic/Capric/Succinic Triglyceride and/or Jojoba Oil/Caprylic/Capric Triglyceride Esters.
  • In particular preferred is Caprylic/Capric Triglyceride. Thus, it is particular preferred if the total quantity of the Caprylic/Capric Triglyceride is in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  • The fatty acid triglyceride can also be part of natural oils. Preferred natural oils, which can be contained are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, avocado oil, tea tree oil, soybean oil, glycine soja oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango kernel oil, cuckoo flower oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter, and shea butter.
  • Further it is preferred if the emulsion comprises least one fatty alcohol ether. It is preferred if the emulsion comprises distearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether as fatty alcohol ether. Further it is preferred if total quantity of fatty alcohol ether is in the range  from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion. Further it is preferred if total quantity of distearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5 %by weight, calculated to the total weight of the emulsion. Most preferred is dicaprylyl ether.
  • According to the invention it is further preferred if the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with acrylic acid and/or methacrylic.
  • According to the invention it is further preferred if the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with 2-acrylamido-2-methylpropanesulfonic acid.
  • Further, it is preferred if the oil phase of the emulsion sums up to a total quantity in the range from 3.0 to 20.0%by weight, more preferably from 5.0 to 15%by weight and most preferably from 6.0 to 12.0%by weight, calculated to the total weight of the emulsion.
  • By definition emulsifier and surfactants are not part of the oil phase. Nevertheless, fatty alcohols count as part of the oil phase.
  • Further compounds which can be contained in the oil phase are for example chosen from further branched saturated or unsaturated fatty alcohols having 6-30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols since they are obtainable according to the Guerbet reaction. Preferred alcohol oils are hexyldecanol ( G 16,  T 16) , octyldodecanol ( G,  20) and 2-ethylhexyl alcohol.
  • Further oils preferred according to the invention are chosen from the addition products of from 1 to 5 propylene oxide units onto mono-or polyhydric C8-22-alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether ( APM) .
  • Further oils, which can be contained in the emulsion according to the invention are chosen from the addition products of at least 6 ethylene oxide and/or propylene oxide units onto mono-or polyhydric C3-22-alkanols, such as butanol, butanediol, myristyl alcohol and stearyl  alcohol, e.g., PPG-14 butyl ether (Ucon AP) , PPG-9 butyl ether ( B25) , PPG-10 butanediol ( 57) and PPG-15 stearyl ether ( E) .
  • Further oils are preferbly chosen from the C8-C22-fatty alcohol esters of monobasic or polybasic C2-C7-hydroxycarboxylic acids, in particular, the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear C14/15-alkanols, e.g., C12-C15-alkyl lactate, and on C12/13-alkanols branched in the 2 position are available under the trade name from Nordmann, Rassmann GmbH &Co., Hamburg, in particular the commercial products ESI,  EMI and  ETI.
  • Further oils which can preferably be used are chosen from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, e.g., glycerol carbonate, dicaprylyl carbonate ( CC) or the esters of DE 197 56 454 A1.
  • Further, it is preferred if the emulsion comprises at least one fatty alcohol comprising 12 to 22 carbon atoms. Among those fatty alcohols cetyl alcohol, stearyl alcohol and the corresponding mixture cetearyl alcohol are most preferred.
  • For the case at least one fatty alcohol comprising 12 to 22 carbon atoms is contained, it is preferred if the total quantity of those fatty alcohols is in the range from 0.5 to 8.0%by weight, more preferably 1.5 to 6.0%by weight and most preferably 2.5 to 5.0 %by weight, calculated to the total weight of the emulsion.
  • According to the invention the emulsion comprises 0.05 to 1%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition. Those gums allow to build up a hydrogel structure in the formulation.
  • It is particular preferred if at least xanthan gum is contained. Further it is particular preferred if at least gellan gum is contained. Further it is particular preferred if at least sclerotium gum is contained. Further it is particular preferred if at least dehydroxanthan gum is contained.
  • It is advantageous if the emulsion comprises 0.1 to 0.8%by weight, more preferably 0.12 to 0.5%by weight and most preferably 0.15 to 0.3%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition.
  • Most preferred is the combination of xanthan gum and gellan gum.
  • Further it is preferred if the emulsion according to the invention comprises further short chain polyols comprising 2 to 8 carbon atoms. Preferred polyols of that type are butylene glycol, glycerol (=glycerin) , propylene glycol, pentylene glycol, butylene glycol, 1, 2 hexanediol, 1, 2 heptanediol, 1, 2 propanediol, methylpropanediol and caprylyl glycol.
  • It is preferred if those preferred polyols are contained in quantities ranging from 0.5 to 10%by weight, more preferably 1 to 9%by weight and most preferably from 1.5 to 8%by weight, calculated to the total weight of the composition.
  • Further it is preferred if the emulsion comprises phenoxyethanol and/or ethylhexylglycerin.
  • For the case that phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 2.0%by weight, preferably from 0.6 to 1.4%by weight, calculated to the total weight of the emulsion.
  • For the case that ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 1.2%by weight, calculated to the total weight of the emulsion.
  • Further it is preferred according to the invention if at least one nonionic emulsifier is contained. Although, basically all nonionic emulsifiers can be contained in the emulsion of the invention, some emulsifiers were found to be particularly beneficial for the effect described. Preferred nonionic emulsifiers are selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil.
  • It is particularly preferred are glyceryl stearate and/or glyceryl stearate SE.
  • For the case that at least one nonionic emulsifier is contained, it is preferred if the total quantity of the nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
  • For the case that at least one nonionic emulsifier selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil is contained, it is preferred if the  total quantity of those nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
  • According to the invention it is also preferred, if at least one anionic emulsifier is contained, which is advantageously selected from the group of anionic emulsifiers having a hlb value ranging from 8 to 18, in particular from 10 to 15.
  • Preferred anionic emulsifiers are selected from glyceryl stearate citrate, sodium cetearyl sulfate and glyceryl citrate.
  • According to the invention it is preferred if the total quantity of anionic emulsifier is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
  • According to the invention it is preferred if the total quantity of glyceryl stearate citrate, sodium cetearyl sulfate and/or glyceryl citrate is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
  • It is also advantageous according to the invention if further active ingredients are contained. These are advantageously selected from the group containing sodium hyaluronate, 1-methylhydantoin-2-imide, creatine, folic acid, panthenol, pantolactone, vitamin C, magnolia, calcium pantothenate and sodium ascorbyl phosphate. The active ingredients mentioned in the group are advantageously used in total proportions of up to 2%by weight, preferably less than 1%by weight, based on the total weight of the composition.
  • Further it is preferred if the emulsion is an oil in water emulsion.
  • Further it is preferred if water is contained in the emulsion in a total quantity ranging from 75.0%by weight to 95.0%by weight, calculated to the total weight of the emulsion.
  • Figures and its brief description
  • Figure 1 shows a picture of Example 1;
  • Figure 2 shows a picture of Example 2;
  • Figure 3 shows a picture of Example 3; and
  • Figure 4 shows a picture of Example 4.
  • Examples
  • The following examples should illustrate the compositions of this invention, without intending to limit the invention to these examples. The numerical values in the examples are percentages by weight, based on the total weight of the preparations.
  • The example Ex. 2 is according to the invention. Ex. 1, Ex. 3 and Ex. 4 are reference examples.
  • Ingrediens Ex. 1 Ex. 2 Ex. 3 Ex. 4
    Methylheptylglycerin 0.6 0.6   0.6
    Isopropyl Palmitate   1 1.6  
    Octyldodecanol       1
    Ethylhexylglycerin 0.2 0.2 0.2 0.2
    Caprylic/Capric Triglyceride 3.05 3.05 3.05 3.05
    Butyrospermum Parkii Butter 1.38 1.38 1.38 1.38
    Sodium Cetearyl Sulfate 0.09 0.09 0.09 0.09
    Glyceryl Stearate SE 2.01 2.01 2.01 2.01
    Glycerin 7 7 7 7
    Phenoxyethanol 0.9 0.9 0.9 0.9
    Cetearyl Alcohol 4.09 4.09 4.09 4.09
    Gellan Gum 0.08 0.08 0.08 0.08
    Xanthan Gum 0.07 0.07 0.07 0.07
    Aqua Ad 100 Ad 100 Ad 100 Ad 100
  • The anti-foaming properties of the formulas above were analyzed in the following manner: 
  • 1. prepare the material: test sample, Pipette which can measure 200μL sample, artificial skin (black PU artificial leather) , metronome, stopwatch, camera, photograph light box, and camera fixing system.
  • 2. Apply 200μL of the example formulation on the left 1/3 of the artificial skin.
  • 3. Start the metronome with 96 bpm, to make sure the spreading frequency is same in each testing.
  • 4. Start the stopwatch to record the spread time, immediately start to spread the product on the artificial skin by moving 3 fingers right and left to the beat of the metronome for 30 sec.
  • 5. Take a picture of the artificial skin. Then use image analyze software (imageJ) to adjust the picture to 8-digit gray mode.
  • 6. The recorded pictures are presented in Figures 1 to 4, wherein the number of the picture corresponds to the number of the example formulation above.
  • Example 1 in the table above is a reference example containing methylheptylglycerin. Example 2 is an example according to the invention containing methylheptylglycerin and isopropylpalmitate. If another oil, e.g., octyldodecanol is added an increase in white foam is observed (Ex. 4) . This applies also, if only the ester is used in absence of methylheptylglycerin (Ex. 3) . Thus, only by applying isopropyl palmitate in combination with methylheptylglycerin allows a synergistic reduction of white foam (Figure 2) .
  • Ingrediens Ex. 5 Ex. 6 Ex. 7 Ex. 8
    Methylheptylglycerin 0.4 0.6 0.5 0.8
    Isopropyl Palmitate   1.0 0.8  
    isononyl isononanoate 1.2      
    isopropyl myristate     0.4  
    C12-15 alkyl benzoate       0.9
    butyl palmitate       0.1
    Dicaprylyl ether   1.0    
    Ethylhexylglycerin 0.2 0.2 0.2 0.2
    Caprylic/Capric Triglyceride 3.05 3.05 3.05 3.05
    Butyrospermum Parkii Butter 1.38 1.38 1.38 1.38
    Sodium Cetearyl Sulfate 0.09 0.09 0.09 0.09
    Glyceryl Stearate SE 2.01 2.01 2.01 2.01
    Glycerin 7 7 7 7
    Phenoxyethanol 0.9 0.9 0.9 0.9
    Cetearyl Alcohol 4.09 4.09 4.09 4.09
    Gellan Gum 0.08 0.08 0.08 0.08
    Xanthan Gum 0.07 0.07 0.07 0.07
    Aqua Ad 100 Ad 100 Ad 100 Ad 100
  • Ingrediens Ex. 9 Ex. 10 Ex. 11 Ex. 12
    Methylheptylglycerin 1.5 3.5 4.5 1.3
    Isopropyl Palmitate 0.6     1.0
    isononyl isononanoate   1.3    
    isopropyl myristate     0.5  
    C12-15 alkyl benzoate       0.9
    butyl palmitate       0.1
    ethyl stearate     1.0  
    Ethylhexylglycerin 0.2 0.2 0.2 0.2
    Caprylic/Capric Triglyceride 3.05 3.05 3.05 3.05
    Butyrospermum Parkii Butter 1.38 1.38 1.38 1.38
    Sodium Cetearyl Sulfate 0.09 0.09 0.09 0.09
    Glyceryl Stearate SE 2.01 2.01 2.01 2.01
    Glycerin 7 7 7 7
    Phenoxyethanol 0.9 0.9 0.9 0.9
  • Cetearyl Alcohol 4.09 4.09 4.09 4.09
    Gellan Gum 0.08 0.08 0.08 0.08
    Xanthan Gum 0.07 0.07 0.07 0.07
    Aqua Ad 100 Ad 100 Ad 100 Ad 100

Claims (15)

  1. Cosmetic emulsion comprising based on the total weight of the composition
    a. 0.05 to 5.0%by weight of methylheptylglycerin,
    b. At least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated,
    c. less than 0.1%or 0%by weight of a silicone oil and/or a silicone compound.
  2. Emulsion according to claim 1 characterized in that the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, preferably from 0.2 to 1.5%by weight and more preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
  3. Emulsion according to any of the proceeding claims characterized in that the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, is in the range from 0.2 to 8.0%by weight, preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  4. Emulsion according to any of the proceeding claims characterized in that the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2-butyl octanoate, diisotridecyl acetate, ethyl stearate, methyl stearate, , propyl stearate, butyl stearate, ethyl myristate, ethyl palmitate, butyl palmitate, propyl stearate, propyl palmitate, stearyl benzoate, benzyl palmitate, benzyl stearate, palmityl benzoate, C12-15 alkyl benzoate, palmityl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl  oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and ethylene glycol dipalmitate.
  5. Emulsion according to claim 4 characterized in that isopropyl myristate and/or isopropyl palmitate are contained.
  6. Emulsion according to claim 5 characterized in that the total quantity of isopropyl myristate and/or isopropyl palmitate is in the range from 0.2 to 8.0%by weight, preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
  7. Emulsion according to any of the proceeding claims characterized in that at least one fatty acid triglyceride is contained in the emulsion.
  8. Emulsion according to claim 7 characterized in that the total quantity of the fatty acid triglycerides is in the range from 0.5 to 8.0%by weight, preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  9. Emulsion according to claim 7 or 8 characterized in that Caprylic/Capric Triglyceride is contained, whereby it is preferred if the total quantity of the Caprylic/Capric Triglyceride is in the range from 0.5 to 8.0%by weight, preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
  10. Emulsion according to any of the proceeding claims characterized in that the oil phase of the emulsion sums up to a total quantity in the range from 3.0 to 20.0%by weight, preferably from 5.0 to 15%by weight and more preferably from 6.0 to 12.0%by weight, calculated to the total weight of the emulsion.
  11. Emulsion according to any of the proceeding claims characterized in that the emulsion comprises 0.05 to 1%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition.
  12. Emulsion according to any of the proceeding claims characterized in that at least one fatty alcohol ether is contained.
  13. Emulsion according to claim 12 characterized in that stearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether are contained as fatty alcohol ether, whereby dicaprylyl ether is preferred.
  14. Emulsion according to claim 13 characterized in that total quantity of distearyl ether, cetyl dimethylbutyl ether and/or dicaprylyl ether is in the range from 0.2 to 8.0%by weight, preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5 %by weight, calculated to the total weight of the emulsion.
  15. Use of methylheptylglycerin in combination with at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, preferably isopropyl myristate and/or isopropyl palmitate, for reducing white foaming in a cosmetic emulsion.
EP22942056.7A 2022-05-19 2022-05-19 COSMETIC EMULSION WITH REDUCED WHITE FOAMING Pending EP4496554A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/093729 WO2023221014A1 (en) 2022-05-19 2022-05-19 Cosmetic emulsion with reduced white foaming

Publications (2)

Publication Number Publication Date
EP4496554A1 true EP4496554A1 (en) 2025-01-29
EP4496554A4 EP4496554A4 (en) 2026-01-07

Family

ID=88834213

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22942056.7A Pending EP4496554A4 (en) 2022-05-19 2022-05-19 COSMETIC EMULSION WITH REDUCED WHITE FOAMING

Country Status (2)

Country Link
EP (1) EP4496554A4 (en)
WO (1) WO2023221014A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4834775B2 (en) * 2010-03-04 2011-12-14 株式会社 資生堂 Sunscreen composition
JP5887072B2 (en) * 2010-06-04 2016-03-16 ロート製薬株式会社 Hyaluronic acid-containing emulsion composition
EP2807925A1 (en) * 2013-05-26 2014-12-03 Symrise AG Antimicrobial compositions
JP6729029B2 (en) * 2016-06-15 2020-07-22 日油株式会社 Cosmetic composition
BR112022021837A2 (en) * 2020-05-22 2022-12-13 Inolex Investment Corp BIOLOGICALLY BASED ALKYL GLYCERYL ETHERS AND METHODS OF PREPARATION AND USE THEREOF
DE102022203484A1 (en) * 2022-04-07 2023-10-12 Henkel Ag & Co. Kgaa Hair treatment product with anti-dandruff effect

Also Published As

Publication number Publication date
EP4496554A4 (en) 2026-01-07
WO2023221014A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
US20200405591A1 (en) Sprayable composition
JP2012136485A (en) Hair treating agent
WO2023221015A1 (en) Cosmetic emulsion with reduced white appearance on skin
FR3052052A1 (en)
FR3044922A1 (en)
WO2023221014A1 (en) Cosmetic emulsion with reduced white foaming
WO2015086005A1 (en) Cosmetic composition containing a combination of oligopeptides and ceramides
FR3058639A1 (en) CONDITIONER FOR HAIR CLEANING
WO2023193962A1 (en) Antidandruff shampoo
EP1704897B1 (en) Foamable cosmetic compositions
WO2024145888A1 (en) Cosmetic emulsion with diisopropyl adipate and polyglycerylester
EP4687813A1 (en) Cosmetic emulsion with reduced white foaming
WO2025081333A1 (en) Cosmetic product with low pilling effect
JP7751983B2 (en) Pet Cleaning Composition
WO2025081336A1 (en) Cosmetic product comprising 4-t-butylcyclohexanol and ectoine
WO2025082638A1 (en) Cosmetic emulsion with low levels of foaming
FR3053248A1 (en) CLEANSING COMPOSITION FOR HAIR
CN122003224A (en) Beauty products with low pilling effect
WO2015086004A1 (en) Cosmetic composition containing a combination of proteolipids and ceramides
FR3053888A1 (en) CONDITIONER FOR HAIR CLEANING
CN107530262A (en) Collecting carbonic anhydride aerosol composition
WO2025081335A1 (en) Cosmetic product comprising 4-t-butylcyclohexanol, polyglyceryl ester and an oil
EP3079774B1 (en) Hair treatment agent containing carboxylic acid-n-alkylpolyhydroxyalkylamides
HK40027750B (en) Oil-in-water type cosmetic composition having high content of stabilized oil
DE102013225548A1 (en) Cosmetic composition useful for care- and/or cleaning of skin and hair, comprises an N-acyl-glutamic acid amide compound, a cationic surfactant, and optionally an alcohol having eight-thirty carbon atoms in alkyl chain

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241022

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NIVEA (SHANGHAI) CO. LTD.

Owner name: BEIERSDORF AG

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20251204

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/34 20060101AFI20251128BHEP

Ipc: A61K 8/37 20060101ALI20251128BHEP

Ipc: A61Q 19/00 20060101ALI20251128BHEP